Ainos Secures Commercial Orders for AI Nose in Semiconductor Manufacturing, Dataset Surpasses 1 Billion

Ainos Advances AI Nose into Commercial Deployment

Ainos has secured initial commercial orders for its AI Nose platform from a front-end semiconductor manufacturer, marking a significant transition from technical validation to commercial deployment2

2

. The announcement sent Ainos stock up 6.9% in premarket trading Monday3

3

. This milestone builds on validation activities initiated in March 2026, when the company deployed approximately 200 AI Nose systems across targeted front-end wafer fabrication environments2

2

. The move represents progress toward the broader revenue-generation opportunities Ainos is pursuing beginning in the second half of 20263

3

.

Chemical Intelligence Dataset Surpasses 1 Billion Records

Alongside the commercial progress in semiconductor manufacturing, Ainos announced its proprietary chemical dataset has surpassed 1 billion records, up from approximately 878 million records reported in August2

2

3

3

. Unlike AI datasets primarily collected from the internet or created through simulation, this proprietary chemical dataset is generated by physical AI Nose systems operating in real-world environments2

2

. Each deployed AI Nose serves dual roles: delivering sensing capabilities for customer applications while functioning as a Physical Edge Node that contributes real-world chemical data to Ainos' broader Chemical Intelligence infrastructure2

2

. Eddy Tsai, Chairman, President and CEO of Ainos, emphasized that "real-world chemical data cannot simply be downloaded from the internet. It must be captured from the physical world"2

2

.

VASRO Research Highlights Growing Commercial Momentum

VASRO GmbH released a research update highlighting strengthening commercial momentum for Ainos' AI Nose platform across semiconductor applications1

1

. The report pointed to two developments as important markers in Ainos' semiconductor commercialization: the transition of its front-end semiconductor program from validation to initial commercial orders, and the expansion of its proprietary real-world chemical dataset beyond 1 billion records1

1

. VASRO noted that the move into initial commercial orders introduces a new commercial stage for Ainos and creates a clearer path toward broader adoption, repeat orders and future revenue contribution1

1

. The research firm also highlighted the company's approximately $2.1 million back-end semiconductor subscription program, where continued deployment and revenue recognition could provide a more visible measure of execution and commercial scale1

1

.

AI Nose Addresses Perception Gap in Semiconductor Manufacturing

Front-end semiconductor manufacturing involves highly complex chemical processes, where subtle shifts in chemical signatures can provide valuable insights into process conditions, equipment performance, and environmental anomalies2

2

. Many of these signals exist outside the perceptual reach of conventional machine vision and audio systems. The AI Nose platform digitizes chemical signatures in manufacturing environments, providing a chemical perception layer that complements conventional monitoring systems3

3

. Rather than replacing existing industrial monitoring systems, AI Nose adds a chemical perception layer that gives machines access to information conventional vision, audio, and digital sensing systems may not capture2

2

. The second-generation platform, launched in August 2026, features upgrades to software, firmware, edge AI capabilities, hardware reliability, modular design, over-the-air capabilities, and fleet management2

2

3

3

.

Data-Driven Flywheel Strategy Takes Shape

VASRO pointed to Ainos' 1 billion-plus chemical dataset as an increasingly important strategic asset that could enable a data-driven flywheel effect1

1

. As commercial deployment expands, AI Nose can generate more semiconductor-specific chemical data, deepen the company's Chemical Intelligence library and support additional use cases1

1

. This creates the potential for a reinforcing cycle in which more deployments generate more machine-readable data, more data enables broader applications, and broader applications can support further deployment1

1

. Tsai explained that "broader deployment generates more proprietary real-world data, strengthening the company's learning foundation and Chemical Intelligence capabilities, which can enhance customer value and support further deployment"2

2

. The company is deploying AI Nose across both front-end wafer fabrication and back-end packaging and testing in semiconductor manufacturing3

3

, positioning edge sensing technology as a critical component of its broader strategy to transform real-world chemical sensing into a scalable commercial platform2

2

.